Your Health, We Care
As a targeted drug for HER2 positive tumors, tucatinib has shown significant efficacy in the treatment of breast cancer and colorectal cancer.
In the MOUTIANEER clinical trial, the combination of tucatinib and trastuzumab in the treatment of HER2 positive metastatic colorectal cancer provided significant survival benefits for patients.
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
